NYSE - Delayed Quote USD

Corteva, Inc. (CTVA)

Compare
58.33 +0.24 (+0.41%)
At close: October 4 at 4:00 PM EDT
58.33 0.00 (0.00%)
After hours: October 4 at 6:18 PM EDT
Loading Chart for CTVA
DELL
  • Previous Close 58.09
  • Open 58.61
  • Bid 58.32 x 900
  • Ask 58.59 x 1100
  • Day's Range 58.11 - 58.77
  • 52 Week Range 43.22 - 59.08
  • Volume 1,326,973
  • Avg. Volume 2,856,485
  • Market Cap (intraday) 40.379B
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) 46.29
  • EPS (TTM) 1.26
  • Earnings Date Nov 6, 2024
  • Forward Dividend & Yield 0.68 (1.17%)
  • Ex-Dividend Date Sep 3, 2024
  • 1y Target Est 63.14

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

www.corteva.com

22,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CTVA

View More

Performance Overview: CTVA

Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CTVA
22.80%
S&P 500
20.57%

1-Year Return

CTVA
17.31%
S&P 500
35.98%

3-Year Return

CTVA
38.67%
S&P 500
31.99%

5-Year Return

CTVA
131.88%
S&P 500
97.59%

Compare To: CTVA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CTVA

View More

Valuation Measures

Annual
As of 10/4/2024
  • Market Cap

    40.38B

  • Enterprise Value

    43.14B

  • Trailing P/E

    46.29

  • Forward P/E

    17.42

  • PEG Ratio (5yr expected)

    1.11

  • Price/Sales (ttm)

    2.43

  • Price/Book (mrq)

    1.60

  • Enterprise Value/Revenue

    2.55

  • Enterprise Value/EBITDA

    17.14

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.31%

  • Return on Assets (ttm)

    2.89%

  • Return on Equity (ttm)

    3.42%

  • Revenue (ttm)

    16.9B

  • Net Income Avi to Common (ttm)

    874M

  • Diluted EPS (ttm)

    1.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.96B

  • Total Debt/Equity (mrq)

    18.58%

  • Levered Free Cash Flow (ttm)

    2.35B

Research Analysis: CTVA

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 6.11B
Earnings 1.05B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

55.00 Low
63.14 Average
58.33 Current
70.00 High
 

Company Insights: CTVA

Research Reports: CTVA

View More
  • Downgrading to HOLD

    Corteva Inc., the former agricultural business of DowDuPont, has two business segments: Seeds and Crop Protection. The Seeds segment provides advanced germplasm and seeds that help farmers optimize yields. The Crop Protection segment develops and markets herbicides.

    Rating
    Price Target
     
  • On Monday, August 5, the S&P 500 (SPX) fell right to its lower channel

    On Monday, August 5, the S&P 500 (SPX) fell right to its lower channel off the lows in October 2022 and March 2023. Yes, that is the trendline we didn't trust because it was busted twice in October 2023. We also got close (at 5,119) to a 78.6% retracement of the rally from April until July (at 5,107). The SPX cycled into oversold territory at 30 on the 14-day relative strength index (RSI), but could become more oversold. The rising 200-day is at 5,012, while the April low is at 4,967. One of our favorite charts is the weekly SPX with the 200-week average and the weekly Bollinger Bands. While we still have some distance, the slightly rising lower band is down near 5,000 as of this writing. A touch/undercut and then a recapture of the lower band generally has indicated an excellent time to buy the index/market. A good confirmation would be a move back over the middle band. But note the failures in 2022's bear market: two times the SPX failed at/near the middle band, while a third move surpassed the middle band but ended up failing The VIX exploded to 66% at the open on August 5, its highest level since the pandemic. The three-day rate-of-change (ROC) was 136%, the highest since early 2018. Since 1990, this is the third-highest three-day ROC. We had a three-day decline of 9% in 2018 and a two-day decline of 6% in 2015. The VIX moves sharply when stocks move lower quickly lower. The three-day SPX decline was 7.3% at the lows on August 5 and ended the day at 6.1%. Both the drops in 2018 and 2015 were followed by a quick rally and then a retest of the lows or a double bottom. Both double bottoms were followed by major rallies that failed.

     
  • Corteva Earnings: Solid Seeds Results Slightly Offset by Weak Crop Protection Profits

    Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.

    Rating
    Price Target
     
  • Mid Cap U.S. Pick List July 2024

    This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.

     

People Also Watch